Allurion Technologies Inc. (ALUR) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Natick, MA, United States. El CEO actual es Samuel G. Levy.
ALUR tiene fecha de IPO 2021-03-29, 134 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $6.79M.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
